Myung Ah Lee

机构：The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea · ORCID：0000-0002-1204-0574

发表论文 237 篇 · 总被引 8303 次 · h-index 38

代表论文

• Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study (2025 · Journal of Hepatology · 被引 68)
• Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma (2024 · Journal of Hepatology · 被引 37)
• Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial (2025 · The Lancet · 被引 28)
• D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial (2025 · Nature Medicine · 被引 21)
• Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation (2025 · Signal Transduction and Targeted Therapy · 被引 20)
• Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries (2024 · Liver Cancer · 被引 14)